title: Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2.
abstract: OBJECTIVE
  Phospholipid transfer protein (PLTP) and cholesteryl ester transfer protein (CETP) are key enzymes in lipoprotein metabolism facilitating the transfer and exchange of cholesteryl esters, triglycerides and phospholipids between lipoproteins. In the study presented here, we investigated the influence of two hormones-the adipocyte-derived hormone leptin as well as insulin on the hepatic secretion of both, PLTP and CETP.
  
  
  METHODS
  PLTP activity and CETP concentration-measured by exogenous substrate assay and enzyme-linked immunosorbent assay-were determined in supernatant of human hepatoma cell line HepG2 after single or combined exposure to leptin and insulin at physiological and supraphysiological concentrations, respectively. Messenger-RNA of PLTP and CETP was quantified by Northern blot analysis.
  
  
  RESULTS
  Leptin suppressed PLTP activity and CETP-concentration by up to 33% and 23%, respectively. Insulin also suppressed PLTP activity by up to 11% and CETP-concentration by up to 16%. In combination, the two hormones had additive suppressive effects for both, PLTP activity and CETP-concentration. Northern blot analysis showed no difference in m-RNA levels after exposure to leptin or insulin.
  
  
  CONCLUSIONS
  Leptin and insulin, both known to increase with body fat mass, suppress production of PLTP and CETP in HepG2 cells. When extrapolated to the in vivo situation, this suppressive effect may constitute a mechanism counteracting the potentially harmful action of lipid transfer proteins, particularly reduction of HDL-cholesterol, in conditions frequently associated with increased plasma triglyceride levels such as obesity and insulin resistance.
authors.affiliation: Department of Medicine, University of Innsbruck, Innsbruck, Austria.
authors.forename: S
authors.initials: S
authors.lastname: Kaser
authors.forename: B
authors.initials: B
authors.lastname: Föger
authors.forename: C F
authors.initials: CF
authors.lastname: Ebenbichler
authors.forename: R
authors.initials: R
authors.lastname: Kirchmair
authors.forename: R
authors.initials: R
authors.lastname: Gander
authors.forename: A
authors.initials: A
authors.lastname: Ritsch
authors.forename: A
authors.initials: A
authors.lastname: Sandhofer
authors.forename: J R
authors.initials: JR
authors.lastname: Patsch
mesh_terms: D015152:Blotting, Northern; D002352:Carrier Proteins / Q000187:drug effects* / Q000235:genetics / Q000378:metabolism*; D053480:Cholesterol Ester Transfer Proteins; D017931:DNA Primers; D004797:Enzyme-Linked Immunosorbent Assay; D006023:Glycoproteins; D022781:Hepatocytes / Q000378:metabolism; D006801:Humans; D007328:Insulin / Q000494:pharmacology*; D020738:Leptin / Q000494:pharmacology*; D008074:Lipoproteins / Q000378:metabolism*; D008565:Membrane Proteins / Q000187:drug effects* / Q000235:genetics; D049294:Phospholipid Transfer Proteins; D012333:RNA, Messenger / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: C506642:CETP protein, human; D002352:Carrier Proteins; D053480:Cholesterol Ester Transfer Proteins; D017931:DNA Primers; D006023:Glycoproteins; D007328:Insulin; D020738:Leptin; D008074:Lipoproteins; D008565:Membrane Proteins; D049294:Phospholipid Transfer Proteins; D012333:RNA, Messenger